NASDAQ: IRMD - IRadimed Corporation

Rentabilität für sechs Monate: +4%
Dividendenrendite: +1.75%
Sektor: Healthcare

Aktionsplan IRadimed Corporation


Über das Unternehmen IRadimed Corporation

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

weitere details
It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IPO date 2014-07-16
ISIN US46266A1097
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 1.19
Дивиденд ао 0.62
Сайт https://www.iradimed.com
Цена ао 52.78
Preisänderung pro Tag: -2.02% (53.38)
Preisänderung pro Woche: -0.0516% (52.33)
Preisänderung pro Monat: -6.1% (55.7)
Preisänderung über 3 Monate: -4.33% (54.67)
Preisänderung über sechs Monate: +4% (50.29)
Preisänderung pro Jahr: +18.9% (43.99)
Preisänderung über 3 Jahre: +1.86% (51.35)
Preisänderung über 5 Jahre: +117.93% (24)
Preisänderung seit Jahresbeginn: -1.32% (53)

Unterschätzung

Name Bedeutung Grad
P/S 8.99 1
P/BV 8.25 1
P/E 34.28 5
EV/EBITDA 27.04 4
Gesamt: 3.63

Effizienz

Name Bedeutung Grad
ROA, % 18.66 6
ROE, % 24.07 7
Gesamt: 6.33

Dividenden

Name Bedeutung Grad
Div yield, % 1.75 4.38
DSI 0.8 8
Gesamt: 3.38

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.102 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 70.29 8
Rentabilität Ebitda, % 102.38 10
Rentabilität EPS, % 72.26 8
Gesamt: 6.8



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Roger E. Susi Founder, Chairman, CEO & President 642.57k 1953 (72 Jahr)
Mr. John F. Glenn CFO & Corporate Secretary 541.71k 1962 (63 Jahr)
Mr. Randy Waddell Vice President of Worldwide Sales & Marketing 446.15k
Mr. Steve Kachelmeyer Vice President of Regulatory Affairs & Quality Assurance 337.83k
Mr. Lynn Neuhardt Vice President of Research & Development 354.95k
Mr. Chris Williamson Executive Vice President of Continuous Improvement & Information Technology N/A
Mr. Matt Garner Controller N/A

Adresse: United States, Winter Springs. FL, 1025 Willa Springs Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.iradimed.com